BR112012009953B1 - dispositivos médicos implantáveis biodegrádaveis formados de material á base de magnésio superpuro - Google Patents
dispositivos médicos implantáveis biodegrádaveis formados de material á base de magnésio superpuro Download PDFInfo
- Publication number
- BR112012009953B1 BR112012009953B1 BR112012009953A BR112012009953A BR112012009953B1 BR 112012009953 B1 BR112012009953 B1 BR 112012009953B1 BR 112012009953 A BR112012009953 A BR 112012009953A BR 112012009953 A BR112012009953 A BR 112012009953A BR 112012009953 B1 BR112012009953 B1 BR 112012009953B1
- Authority
- BR
- Brazil
- Prior art keywords
- super
- alloy
- pure
- magnesium
- medical
- Prior art date
Links
- 239000011777 magnesium Substances 0.000 title claims abstract description 123
- 229910052749 magnesium Inorganic materials 0.000 title claims abstract description 117
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title claims abstract description 116
- 239000000463 material Substances 0.000 title abstract description 28
- 239000000956 alloy Substances 0.000 claims abstract description 184
- 229910045601 alloy Inorganic materials 0.000 claims abstract description 183
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 69
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 63
- 239000004035 construction material Substances 0.000 claims description 60
- 239000012535 impurity Substances 0.000 claims description 46
- 229910052742 iron Inorganic materials 0.000 claims description 35
- 229910052802 copper Inorganic materials 0.000 claims description 32
- 239000010949 copper Substances 0.000 claims description 32
- 229910052759 nickel Inorganic materials 0.000 claims description 32
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 31
- 229910017052 cobalt Inorganic materials 0.000 claims description 27
- 239000010941 cobalt Substances 0.000 claims description 27
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 27
- 229910052738 indium Inorganic materials 0.000 claims description 27
- 229910052727 yttrium Inorganic materials 0.000 claims description 26
- 229910052706 scandium Inorganic materials 0.000 claims description 25
- 229910052733 gallium Inorganic materials 0.000 claims description 23
- SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 claims description 22
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims description 21
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims description 20
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000003550 marker Substances 0.000 claims description 6
- 150000002910 rare earth metals Chemical class 0.000 claims description 5
- 229910001092 metal group alloy Inorganic materials 0.000 claims description 2
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 230000007797 corrosion Effects 0.000 abstract description 69
- 238000005260 corrosion Methods 0.000 abstract description 69
- 239000004566 building material Substances 0.000 abstract description 14
- 238000001727 in vivo Methods 0.000 abstract description 7
- 229910000861 Mg alloy Inorganic materials 0.000 description 44
- 229910052751 metal Inorganic materials 0.000 description 24
- 239000002184 metal Substances 0.000 description 24
- 238000012360 testing method Methods 0.000 description 20
- 238000001125 extrusion Methods 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000005275 alloying Methods 0.000 description 9
- 239000011701 zinc Substances 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 7
- 238000000137 annealing Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 238000007792 addition Methods 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 5
- 150000001875 compounds Chemical group 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229910052776 Thorium Inorganic materials 0.000 description 4
- 229910052790 beryllium Inorganic materials 0.000 description 4
- 229910052793 cadmium Inorganic materials 0.000 description 4
- 229910052804 chromium Inorganic materials 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 208000037803 restenosis Diseases 0.000 description 4
- 239000011265 semifinished product Substances 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 229910052785 arsenic Inorganic materials 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 238000009864 tensile test Methods 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical group Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910002056 binary alloy Inorganic materials 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005242 forging Methods 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- -1 indium chemical compounds Chemical class 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000012890 simulated body fluid Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 229910052692 Dysprosium Inorganic materials 0.000 description 1
- 229910052691 Erbium Inorganic materials 0.000 description 1
- 229910000640 Fe alloy Inorganic materials 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- 229910052689 Holmium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910052765 Lutetium Inorganic materials 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 229910017857 MgGa Inorganic materials 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229910052779 Neodymium Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910052777 Praseodymium Inorganic materials 0.000 description 1
- 229910052773 Promethium Inorganic materials 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- 241001351225 Sergey Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 229910052775 Thulium Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910001080 W alloy Inorganic materials 0.000 description 1
- 229910000946 Y alloy Inorganic materials 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 229910001297 Zn alloy Inorganic materials 0.000 description 1
- 229910001093 Zr alloy Inorganic materials 0.000 description 1
- PGTXKIZLOWULDJ-UHFFFAOYSA-N [Mg].[Zn] Chemical compound [Mg].[Zn] PGTXKIZLOWULDJ-UHFFFAOYSA-N 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 238000001033 granulometry Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002608 intravascular ultrasound Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 238000000322 laser mass spectrometry Methods 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 description 1
- 150000002680 magnesium Chemical class 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 239000010955 niobium Substances 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- RJSRQTFBFAJJIL-UHFFFAOYSA-N niobium titanium Chemical compound [Ti].[Nb] RJSRQTFBFAJJIL-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- PUDIUYLPXJFUGB-UHFFFAOYSA-N praseodymium atom Chemical compound [Pr] PUDIUYLPXJFUGB-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- VQMWBBYLQSCNPO-UHFFFAOYSA-N promethium atom Chemical compound [Pm] VQMWBBYLQSCNPO-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- VSZWPYCFIRKVQL-UHFFFAOYSA-N selanylidenegallium;selenium Chemical compound [Se].[Se]=[Ga].[Se]=[Ga] VSZWPYCFIRKVQL-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- 210000003270 subclavian artery Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- FRNOGLGSGLTDKL-UHFFFAOYSA-N thulium atom Chemical compound [Tm] FRNOGLGSGLTDKL-UHFFFAOYSA-N 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25649609P | 2009-10-30 | 2009-10-30 | |
| EP09174604 | 2009-10-30 | ||
| PCT/EP2010/066431 WO2011051424A1 (en) | 2009-10-30 | 2010-10-29 | Biodegradable implantable medical devices formed from super - pure magnesium-based material |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112012009953A2 BR112012009953A2 (pt) | 2016-03-08 |
| BR112012009953B1 true BR112012009953B1 (pt) | 2018-08-28 |
Family
ID=42357414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012009953A BR112012009953B1 (pt) | 2009-10-30 | 2010-10-29 | dispositivos médicos implantáveis biodegrádaveis formados de material á base de magnésio superpuro |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20120215301A1 (enExample) |
| EP (1) | EP2493523B1 (enExample) |
| JP (1) | JP5830467B2 (enExample) |
| CN (1) | CN102802689B (enExample) |
| AU (1) | AU2010311439B2 (enExample) |
| BR (1) | BR112012009953B1 (enExample) |
| CA (1) | CA2779067C (enExample) |
| DK (1) | DK2493523T3 (enExample) |
| EA (1) | EA029095B1 (enExample) |
| ES (1) | ES2487631T3 (enExample) |
| IL (1) | IL219395A (enExample) |
| MX (1) | MX2012004555A (enExample) |
| NZ (1) | NZ599548A (enExample) |
| PL (1) | PL2493523T3 (enExample) |
| PT (1) | PT2493523E (enExample) |
| TW (1) | TWI517865B (enExample) |
| WO (1) | WO2011051424A1 (enExample) |
| ZA (1) | ZA201202911B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2481825B1 (en) * | 2011-02-01 | 2013-05-08 | Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH | Magnesium alloy containing rare earth metals |
| US20130090741A1 (en) * | 2011-10-07 | 2013-04-11 | Medtronic Vascular, Inc. | Magnesium Alloys for Bioabsorbable Stent |
| EP2630978B1 (de) | 2012-02-22 | 2018-10-31 | Biotronik AG | Implantat und verfahren zur herstellung desselben |
| EP2656944B1 (de) | 2012-04-23 | 2018-03-21 | Biotronik AG | Verfahren zur Herstellung eines Implantats |
| KR102246887B1 (ko) * | 2012-06-26 | 2021-05-03 | 바이오트로닉 아게 | 마그네슘-알루미늄-아연 합금, 이의 제조방법 및 이의 용도 |
| CN109022980A (zh) | 2012-06-26 | 2018-12-18 | 百多力股份公司 | 镁合金、其生产方法及其用途 |
| CA2869103C (en) * | 2012-06-26 | 2023-05-02 | Biotronik Ag | Magnesium-zinc-calcium alloy, method for production thereof and use thereof |
| SG11201406024QA (en) * | 2012-06-26 | 2014-10-30 | Biotronik Ag | Magnesium alloy, method for the production thereof and use thereof |
| US9603728B2 (en) * | 2013-02-15 | 2017-03-28 | Boston Scientific Scimed, Inc. | Bioerodible magnesium alloy microstructures for endoprostheses |
| CN104109786B (zh) * | 2013-04-22 | 2016-10-05 | 比亚迪股份有限公司 | 一种镁合金及其制备方法 |
| EP3050996A4 (en) * | 2013-09-24 | 2017-10-04 | Olympus Corporation | Implant and manufacturing method therefor |
| US9522220B2 (en) | 2013-10-29 | 2016-12-20 | Boston Scientific Scimed, Inc. | Bioerodible magnesium alloy microstructures for endoprostheses |
| JP2015119893A (ja) * | 2013-12-25 | 2015-07-02 | 堤総研株式会社 | 生体器具 |
| US10327890B2 (en) * | 2014-01-22 | 2019-06-25 | Biotronik Ag | Thermochemically treated miniature tubes as semifinished products for vascular stents |
| US10426869B2 (en) | 2014-05-05 | 2019-10-01 | The University Of Toledo | Biodegradable magnesium alloys and composites |
| KR101722310B1 (ko) * | 2015-02-17 | 2017-03-31 | 서울대학교산학협력단 | 생체 분해성 마그네슘 및 생체 분해성 마그네슘의 분해속도 제어방법 |
| JP2018515156A (ja) | 2015-03-11 | 2018-06-14 | ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． | 体内プロテーゼ用の生体分解性マグネシウム合金の微細構造 |
| EP3399060B1 (en) | 2015-12-28 | 2022-08-24 | Korea Institute Of Materials Science | Method for manufacturing magnesium alloy having excellent mechanical properties and corrosion resistance |
| KR101976074B1 (ko) * | 2017-07-10 | 2019-05-08 | 주식회사 엠아이텍 | 생분해성 스텐트 제조 방법 |
| CN110541098A (zh) * | 2019-10-22 | 2019-12-06 | 中南大学 | 一种耐腐蚀生物镁铟合金及其制备方法和应用 |
| WO2021119391A1 (en) * | 2019-12-12 | 2021-06-17 | Edwards Lifesciences Corporation | Hybrid annuloplasty ring |
| CN111571128B (zh) * | 2020-05-07 | 2022-07-05 | 沪创医疗科技（上海）有限公司 | 生物可降解超细晶镁合金血管内支架的制备方法 |
| CN111922648B (zh) * | 2020-08-14 | 2021-06-29 | 北京理工大学 | 一种可降解镁合金心血管支架的精雕加工方法 |
| EP4260882A4 (en) * | 2020-12-14 | 2024-10-16 | Nitto Seiko Co., Ltd. | Biodegradable medical implement |
| CN113017733A (zh) * | 2021-03-30 | 2021-06-25 | 苏州奥芮济医疗科技有限公司 | 一种医疗锚钉及其加工工艺 |
| JP2023124565A (ja) * | 2022-02-25 | 2023-09-06 | 日東精工株式会社 | 生分解性医療器具 |
| WO2025023199A1 (ja) * | 2023-07-24 | 2025-01-30 | 日東精工株式会社 | マグネシウムワイヤ、マグネシウムワイヤの製造方法、および、マグネシウムワイヤの評価方法 |
| CN118835122B (zh) * | 2024-09-14 | 2025-08-08 | 广州众山轻合金有限公司 | 一种用于医疗器械的半固态合金材料及其制备方法 |
| CN119819946B (zh) * | 2025-03-17 | 2025-06-17 | 吉林大学 | 一种激光粉末床熔化制备可降解镁合金血管支架的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5582630A (en) * | 1995-02-21 | 1996-12-10 | Sony Corporation | Ultra high purity magnesium vacuum distillation purification method |
| DE19731021A1 (de) | 1997-07-18 | 1999-01-21 | Meyer Joerg | In vivo abbaubares metallisches Implantat |
| DE59913189D1 (de) | 1998-06-25 | 2006-05-04 | Biotronik Ag | Implantierbare, bioresorbierbare Gefässwandstütze, insbesondere Koronarstent |
| DE10128100A1 (de) | 2001-06-11 | 2002-12-19 | Hannover Med Hochschule | Medizinisches Implantat für den menschlichen und tierischen Körper |
| JP3857589B2 (ja) * | 2002-01-28 | 2006-12-13 | 同和鉱業株式会社 | 高純度金属の精製方法及び精製装置 |
| DE10253634A1 (de) | 2002-11-13 | 2004-05-27 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Endoprothese |
| EP1835042A1 (en) | 2006-03-18 | 2007-09-19 | Acrostak Corp. | Magnesium-based alloy with improved combination of mechanical and corrosion characteristics |
| US20090131540A1 (en) * | 2006-03-20 | 2009-05-21 | National Institute For Materials Science | Biodegradable Magnesium Based Metallic Material for Medical Use |
| KR20080113280A (ko) * | 2006-04-28 | 2008-12-29 | 바이오마그네슘 시스템즈 리미티드 | 생물분해성 마그네슘 합금 및 그 용도 |
| ATE482296T1 (de) | 2007-05-28 | 2010-10-15 | Acrostak Corp Bvi | Magnesiumbasierte legierungen |
| DE102007043883A1 (de) | 2007-09-14 | 2009-03-26 | Biotronik Vi Patent Ag | Stent mit einer Beschichtung |
| DE102008002601A1 (de) | 2008-02-05 | 2009-08-06 | Biotronik Vi Patent Ag | Implantat mit einem Grundkörper aus einer biokorrodierbaren Eisenlegierung |
-
2010
- 2010-10-29 PT PT107797342T patent/PT2493523E/pt unknown
- 2010-10-29 WO PCT/EP2010/066431 patent/WO2011051424A1/en not_active Ceased
- 2010-10-29 NZ NZ599548A patent/NZ599548A/xx not_active IP Right Cessation
- 2010-10-29 BR BR112012009953A patent/BR112012009953B1/pt not_active IP Right Cessation
- 2010-10-29 DK DK10779734.2T patent/DK2493523T3/da active
- 2010-10-29 CA CA2779067A patent/CA2779067C/en not_active Expired - Fee Related
- 2010-10-29 TW TW099137316A patent/TWI517865B/zh not_active IP Right Cessation
- 2010-10-29 ES ES10779734.2T patent/ES2487631T3/es active Active
- 2010-10-29 US US13/505,220 patent/US20120215301A1/en not_active Abandoned
- 2010-10-29 AU AU2010311439A patent/AU2010311439B2/en not_active Ceased
- 2010-10-29 EP EP10779734.2A patent/EP2493523B1/en not_active Revoked
- 2010-10-29 CN CN201080060323.XA patent/CN102802689B/zh not_active Expired - Fee Related
- 2010-10-29 PL PL10779734T patent/PL2493523T3/pl unknown
- 2010-10-29 MX MX2012004555A patent/MX2012004555A/es active IP Right Grant
- 2010-10-29 JP JP2012535841A patent/JP5830467B2/ja not_active Expired - Fee Related
- 2010-10-29 EA EA201200685A patent/EA029095B1/ru not_active IP Right Cessation
-
2012
- 2012-04-20 ZA ZA2012/02911A patent/ZA201202911B/en unknown
- 2012-04-24 IL IL219395A patent/IL219395A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2493523A1 (en) | 2012-09-05 |
| PL2493523T3 (pl) | 2014-11-28 |
| BR112012009953A2 (pt) | 2016-03-08 |
| CN102802689A (zh) | 2012-11-28 |
| JP2013509217A (ja) | 2013-03-14 |
| EA029095B1 (ru) | 2018-02-28 |
| IL219395A0 (en) | 2012-06-28 |
| CN102802689B (zh) | 2014-12-17 |
| AU2010311439B2 (en) | 2013-06-20 |
| ES2487631T3 (es) | 2014-08-22 |
| EA201200685A1 (ru) | 2012-11-30 |
| TWI517865B (zh) | 2016-01-21 |
| EP2493523B1 (en) | 2014-06-18 |
| WO2011051424A1 (en) | 2011-05-05 |
| CA2779067C (en) | 2016-05-03 |
| PT2493523E (pt) | 2014-08-05 |
| US20120215301A1 (en) | 2012-08-23 |
| TW201130525A (en) | 2011-09-16 |
| NZ599548A (en) | 2013-04-26 |
| JP5830467B2 (ja) | 2015-12-09 |
| DK2493523T3 (da) | 2014-09-01 |
| ZA201202911B (en) | 2013-06-26 |
| MX2012004555A (es) | 2012-08-03 |
| CA2779067A1 (en) | 2011-05-05 |
| AU2010311439A1 (en) | 2012-05-17 |
| IL219395A (en) | 2016-09-29 |
| HK1175126A1 (en) | 2013-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012009953B1 (pt) | dispositivos médicos implantáveis biodegrádaveis formados de material á base de magnésio superpuro | |
| Riaz et al. | The current trends of Mg alloys in biomedical applications—A review | |
| KR102081363B1 (ko) | 마그네슘-아연-칼슘 합금, 이의 제조방법 및 이의 용도 | |
| RU2647951C2 (ru) | Магниевый сплав, способ его производства и использования | |
| Ma et al. | Similarities and differences in coatings for magnesium-based stents and orthopaedic implants | |
| JP6768295B2 (ja) | マグネシウム合金、その製造方法およびその使用 | |
| CN102438669B (zh) | 并入过饱和镁合金的可生物消蚀、植入式医疗设备 | |
| AU2011231630B2 (en) | Implant made of a biodegradable magnesium alloy | |
| US8268235B2 (en) | Implant with a base body of a biocorrodible magnesium alloy | |
| US6786984B1 (en) | Ternary alloy and apparatus thereof | |
| CN111304504A (zh) | 具有可调节降解率的超纯镁合金 | |
| Bîrcă et al. | Mg–Zn alloys, most suitable for biomedical applications | |
| Nowosielski et al. | Fabrication and properties of magnesium based alloys Mg-Ca | |
| Cesarz-Andraczke et al. | Amorphous and crystalline magnesium alloys for biomedical applications | |
| HK1175126B (en) | Biodegradable implantable medical devices formed from super-pure magnesium-based material | |
| US20240225700A1 (en) | Extruded lean magnesium-calcium alloys | |
| Kubok | of microstructure and properties of biodegradable alloys from the Mg-Zn-Ca system | |
| SAHINOJA | STUDY OF MAGNESIUM METAL AND ITS ALLOYS AS A BIODEGRADABLE MATERIAL FOR MEDICAL AND ELECTRICAL APPLICATIONS | |
| BR112014032618B1 (pt) | Liga de magnésio, método para sua produção e modo de utilização da liga |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/10/2010, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2642 DE 24-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |